Crosslinking in Children and Down Syndrome Patients
暂无分享,去创建一个
[1] A. Frings,et al. Quality of life in stable and progressive ‘early‐stage’ keratoconus patients , 2020, Acta ophthalmologica.
[2] R. Nuijts,et al. Clinical Evaluation and Validation of the Dutch Crosslinking for Keratoconus Score. , 2019, JAMA ophthalmology.
[3] M. Mangen,et al. Cost-Effectiveness Analysis of Corneal Collagen Crosslinking for Progressive Keratoconus. , 2017, Ophthalmology.
[4] C. Uiterwaal,et al. Age-specific Incidence and Prevalence of Keratoconus: A Nationwide Registration Study. , 2017, American journal of ophthalmology.
[5] M. Mangen,et al. Comment on ‘Cost effectiveness of collagen crosslinking for progressive keratoconus in the UK NHS’ , 2016, Eye.
[6] A. Guneş,et al. The Youngest Patient with Bilateral Keratoconus Secondary to Chronic Persistent Eye Rubbing , 2015, Seminars in ophthalmology.
[7] M. Wagoner,et al. Inverse relationship between age and severity and sequelae of acute corneal hydrops associated with keratoconus , 2007, British Journal of Ophthalmology.
[8] N. Sarvananthan,et al. Does ethnic origin influence the incidence or severity of keratoconus? , 2000, Eye.